Showing results (111-120 of 636) with videos related to
Sort By:
Pageof 64
The Journal of Urology|May 1, 1991
Prostate specific antigen levels after definitive irradiation for carcinoma of the prostateP F Schellhammer, S M Schlossberg, A M el-Mahdi, et al.Urology|November 1, 1986
Characteristics of spinal cord compression in adenocarcinoma of prostateD A Kuban, A M el-Mahdi, S V Sigfred, et al.Der Urologe. Ausg. A|May 8, 2002
[Laparoscopic radical cystectomy with intracorporeal creation of a continent urinary diversion. Future or present?]I Türk, J W Davis, S Deger, et al.Clinical Therapeutics|May 24, 2000
Management of patients with Bacilli Calmette-Guérin-refractory carcinoma in situ of the urinary bladder: cost implications of a clinical trial for valrubicinA Marchetti, L Wang, R Magar, et al.American Journal of Clinical Oncology|August 1, 1997
Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trialJ A Kish, M K Wolf, P F Schellhammer, et al.The Journal of Urology|December 1, 1995
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects of monotherapyM S Soloway, P F Schellhammer, J A Smith, et al.The Prostate|January 1, 1981
Leukocyte migration inhibition assay in patients with prostate adenocarcinomaG L Wright, P F Schellhammer, R J Faulconer, et al.Cancer Research|August 1, 1982
Monoclonal antibodies to human prostate and bladder tumor-associated antigensJ J Starling, S M Sieg, M L Beckett, et al.Urology|April 18, 2001
Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic reviewB Schmitt, T J Wilt, P F Schellhammer, et al.Cancer Genetics and Cytogenetics|February 1, 1989
Cytogenetic analysis of four primary prostatic culturesA R Brothman, L J Lesho, K D Somers, et al.Pageof 64